INTRODUCTION: Donor shortage and organ allocation is the main problem in pediatric heart transplant. Mechanical circulatory support is known to increase waiting list survival, but it is not routinely used in pediatric programs in Latin America. METHODS: All patients listed for heart transplant and supported by a mechanical circulatory support between January 2012 and March 2016 were included in this retrospective single-center study. The endpoints were mechanical circulatory support time, complications, heart transplant survival and discharge from the hospital. RESULTS: Twenty-nine patients from our waiting list were assessed. Twelve (45%) patients were initially supported by extracorporeal membrane oxygenation (ECMO) and a centrifugal pump was implanted in 17 (55%) patients. Five patients initially supported by ECMO were bridged to another device. One was bridged to a centrifugal pump and four were bridged to Berlin Heart Excor®. Among the 29 supported patients, 18 (62%) managed to have a heart transplant. Thirty-day survival period after heart transplant was 56% (10 patients). Median support duration was 12 days (interquartile range [IQR] 4 - 26 days) per run and the waiting time for heart transplant was 9.5 days (IQR 2.5-25 days). Acute kidney injury was identified as a mortality predictor (OR=22.6 [CI=1.04-494.6]; P=0.04). CONCLUSION: Mechanical circulatory support was able to bridge most INTERMACS 1 and 2 pediatric patients to transplant with an acceptable complication rate. Acute renal failure increased mortality after mechanical circulatory support in our experience.
INTRODUCTION:Donor shortage and organ allocation is the main problem in pediatric heart transplant. Mechanical circulatory support is known to increase waiting list survival, but it is not routinely used in pediatric programs in Latin America. METHODS: All patients listed for heart transplant and supported by a mechanical circulatory support between January 2012 and March 2016 were included in this retrospective single-center study. The endpoints were mechanical circulatory support time, complications, heart transplant survival and discharge from the hospital. RESULTS: Twenty-nine patients from our waiting list were assessed. Twelve (45%) patients were initially supported by extracorporeal membrane oxygenation (ECMO) and a centrifugal pump was implanted in 17 (55%) patients. Five patients initially supported by ECMO were bridged to another device. One was bridged to a centrifugal pump and four were bridged to Berlin Heart Excor®. Among the 29 supported patients, 18 (62%) managed to have a heart transplant. Thirty-day survival period after heart transplant was 56% (10 patients). Median support duration was 12 days (interquartile range [IQR] 4 - 26 days) per run and the waiting time for heart transplant was 9.5 days (IQR 2.5-25 days). Acute kidney injury was identified as a mortality predictor (OR=22.6 [CI=1.04-494.6]; P=0.04). CONCLUSION: Mechanical circulatory support was able to bridge most INTERMACS 1 and 2 pediatric patients to transplant with an acceptable complication rate. Acute renal failure increased mortality after mechanical circulatory support in our experience.
Authors: Anne I Dipchand; Richard Kirk; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Jason D Christie; Fabienne Dobbels; Lars H Lund; Axel O Rahmel; Roger D Yusen; Josef Stehlik Journal: J Heart Lung Transplant Date: 2013-10 Impact factor: 10.247
Authors: E Azeka; M B Jatene; I B Jatene; E S K Horowitz; K C Branco; J D Souza Neto; N Miura; S Mattos; J Y Afiune; A C Tanaka; C C L Santos; I C B Guimarães; P H Manso; R C R S Pellizari; M V C Santos; A M Thomaz; L M Cristofani; A C L Ribeiro; L D Kulikowski; M C Sampaio; A C Pereira; Am Soares; J Soares Junior; G H Y Oh; V Moreira; C C C Mota; C M C Afiune; C Pedra; S Pedra; A Pedrosa; V Guimarães; L F Caneo; C F Ferreiro; C Cavalheiro Filho; B Stefanello; C E Negrão; A L R Turquetto; S M F Mesquita; W F Maeda; L Zorzanelli; N Panajotopolos; A W S Siqueira; F R B Galas; L A Hajjar; L A Benvenuti; P Vincenzi; V Odone; M H Lopes; T M V Strabelli; S M Franchi; A D Takeuti; M F Duarte; R G P Leon; R P M Hermida; I C E Sorpreso; J M Soares Junior; N R Melo; E C Baracat; M R F L Bortolotto; M Scanavacca; M S Shimoda; G Foronda; B W Romano; D B Silva; M M Omura; C P M Barbeiro; A R G Vinhole; J S H Palomo; M A B Gonçalves; I C F Reis; L G Oliveira; C C Ribeiro; M Isosaki; L P Vieira; M I Z Feltrim; L A Manoel; K C O Abud; D R Paschotto; I L I Neves; L E Senaha; A C C N Garcia; S L Cipriano; V C Santos; A S Ferraz; A E L C Moreira; A R S A De Paulo; A M P C Duque; E Trindade; F Bacal; J O C Auler Junior; D R Almeida Journal: Arq Bras Cardiol Date: 2014-12 Impact factor: 2.000
Authors: Alan W Nugent; Piers E F Daubeney; Patty Chondros; John B Carlin; Michael Cheung; Lynette C Wilkinson; Andrew M Davis; Stephen G Kahler; C W Chow; James L Wilkinson; Robert G Weintraub Journal: N Engl J Med Date: 2003-04-24 Impact factor: 91.245
Authors: Guillermo E Moreno; Ricardo Magliola; María Luisa Pilán; María Althabe; María Balestrini; Ana Miriam Lenz; Mariela Krysnki; Ricardo Rodríguez; Gladys Salgado; Analía Martin; Hugo Cardoso; Pablo Ruffa; Carlos Javier Cornelis; Jorge Barreta; Pablo García Delucis Journal: Arch Cardiol Mex Date: 2014-07-04
Authors: Elizabeth D Blume; David N Rosenthal; Joseph W Rossano; J Timothy Baldwin; Pirooz Eghtesady; David L S Morales; Ryan S Cantor; Jennifer Conway; Angela Lorts; Christopher S Almond; David C Naftel; James K Kirklin Journal: J Heart Lung Transplant Date: 2016-02-10 Impact factor: 10.247
Authors: Rodrigo Freire Bezerra; Juliana Torres Pacheco; Victor Hugo Volpatto; Sônia Meiken Franchi; Rosangela Fitaroni; Denilson Vieira da Cruz; Rodrigo Moreira Castro; Luciana da Fonseca da Silva; José Pedro da Silva Journal: Front Pediatr Date: 2022-03-02 Impact factor: 3.418